Abstract
The use of non-viral vectors like plasmid DNA (pDNA) in gene therapy and DNA vaccination studies has been limited by their low efficiency compared to viral vectors. This is mainly due to the limited capacity to overcome physical, enzymatic and diffusional barriers in the transport to the nuclei of target cells. Besides that limitation, the lack of systematic studies of the influence of no…